Skip to main content
. 2022 Jul 26;13:342. doi: 10.1186/s13287-022-03027-3

Fig. 2.

Fig. 2

C/EBPα inhibits osteogenic differentiation of BMSCs. a The specific surface markers of BMSCs analysed by flow cytometry. bd The establishment of knockdown or overexpression of C/EBPα determined by RT–qPCR and western blot analysis, respectively. e, f Alizarin red staining of osteogenic differentiation of BMSCs in each group and quantitative analysis by ImageJ. gi The protein or mRNA levels of osteogenesis-related genes in BMSCs. ***P < 0.001, **P < 0.01, *P < 0.05